Pricing Log in Create free account

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs CytoMed Therapeutics Limited (GDTC)

Chemomab Therapeutics Ltd. Sponsored ADR and CytoMed Therapeutics Limited are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and CytoMed Therapeutics Limited are of similar size ($9.9M and $9.8M). Across the 10 metrics below, CytoMed Therapeutics Limited leads on 7 and Chemomab Therapeutics Ltd. Sponsored ADR on 3.

Valuation

Metric CMMB GDTC Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 1.24 0.55 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (59.26%) (33.33%) (32.28%)
Free cash flow yield (337.00%) (0.40%) (22.27%)

Profitability

Metric CMMB GDTC Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (82.17%) 0.00% (50.30%)
Return on assets (70.70%) 0.00% (45.47%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB GDTC Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 53.65% (68.75%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB GDTC Biotechnology median
Debt to equity 0.00 80.30 0.00
Current ratio 6.41 2.64 4.74
Net debt to EBITDA 1.09 0.86 1.01

Dividend

Metric CMMB GDTC Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CMMB GDTC Biotechnology median
Market cap 9.75m 9.89m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack